Intrinsic Value of S&P & Nasdaq Contact Us

Orchid Ventures, Inc. ORVRF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
47/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Orchid Ventures, Inc. (ORVRF) reported total assets of $0.00 and total liabilities of $0.00 for quarter ending 2023-09-30, resulting in total equity of $0.00.

The company held $0.00 in cash and short-term investments. Total debt stood at $0.00.

Criteria supported by this page:

  • HEALTH (50/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
  • MOAT (36/100) — Total assets $0.00 and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 43/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
36/100
Proven by this page
GROWTH
100/100
→ Income
INCOME
N/A
No coverage
Orchid Ventures, Inc. Balance Sheet History
Metric Q1 FY2024 Q4 FY2023 Q3 FY2023 Q2 FY2023
Total Assets $0.00$0.00$0.00$0.00
Total Liabilities $0.00$0.00$0.00$0.00
Total Debt $0.00$0.00$0.00$0.00
Cash & Investments $0.00$0.00$0.00$0.00
Total Stockholders Equity $0.00$0.00$0.00$0.00
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message